Happy Christmas, Traders!…👋

Merry Christmas Eve! 🎄 Wishing you a day filled with warmth, joy, and the magic of the season.

U.S. stock futures are mixed this Tuesday, with technology stocks leading the charge as the festive "Santa Claus Rally" continues to unfold. Notably, MicroStrategy and Palantir joined the Nasdaq 100 on Monday, adding momentum to the tech sector.

Global markets are painting a mixed picture. Benchmarks in Shanghai and Hong Kong rose more than 1%, while Seoul and Tokyo closed modestly lower. Europe’s Stoxx 600 also inched higher.

Treasury yields remain steady, with the 10-year yield holding just under 4.6%. Meanwhile, Bitcoin edged upward to approximately $94,000, signaling stability in the crypto market.

Happening Today

Christmas - Early close at 13:00

PREMARKET SNAPSHOT 📈

Market futures are mixed, with the S&P 500 and NASDAQ showing gains, while the Dow is nearly flat with a slight decline.

Message by Our Sponsor

Savvy Investors Know Where to Get Their News—Do You?

Here’s the truth: there is no magic formula when it comes to building wealth.

Much of the mainstream financial media is designed to drive traffic, not good decision-making. Whether it’s disingenuous headlines or relentless scare tactics used to generate clicks, modern business news was not built to serve individual investors.

Luckily, we have The Daily Upside. Created by Wall Street insiders and bankers, this fresh, insightful newsletter delivers valuable insights that go beyond the headlines.

And the best part? It’s completely free. Join 1M+ readers and subscribe today.

SECTOR SNAPSHOT✨

Yesterday market showed a mixed performance with strong gains in key sectors. Consumer discretionary, health care, and information technology led the upward momentum, reflecting robust investor confidence. Communication services and real estate also contributed positively, while energy posted moderate gains. On the other hand, consumer staples and industrials experienced minor declines, and materials showed a slight dip, reflecting selective sectoral pressures. Overall, the market remained resilient with broad participation across most sectors.

PreMarket Unusual Volume Stocks

📈 Baosheng Media Group Holdings Ltd (BAOS) experienced a significant price surge of 126.59%, closing at 3.92. The trading volume hit 10,653,215 shares, vastly exceeding its average volume of 24.42.

📈 Avinger Inc (AVGR) showcased an exceptional 198.88% increase, with its stock price closing at 1.92. The trading volume skyrocketed to 40,496,095 shares, well above its average of 195.04.

📈 Auddia Inc (AUUD) saw a price growth of 27.40%, closing at 0.61. The trading volume was 10,560,485 shares, far surpassing its average volume of 140.35.

📈 Clearmind Medicine Inc (CMND) recorded a strong gain of 107.38%, with its stock price closing at 2.53. The trading volume stood at 7,036,364 shares, significantly higher than its average volume of 262.72.

📈 Carbon Revolution Public Ltd. Co (CREV) experienced a solid increase of 47.81%, closing at 5.75. The trading volume reached 1,121,931 shares, surpassing its average volume of 85.15.

Premarket Picks

Clearmind Medicine Inc. (CMND) saw a significant increase in its stock price, reaching $2.54, marking a surge of 109.91%. This jump followed the company’s receipt of IRB approval for its FDA-regulated clinical trial, a major milestone for its clinical research efforts.

Carbon Revolution Public Limited Company (CREV) experienced a pre-market surge of 47.30%, with its stock reaching $5.73. This rise came after the company secured a new $25 million financing agreement with OIC and existing lenders, providing valuable financial backing.

Tivic Health Systems, Inc. (TIVC) saw its stock price climb to $0.43, an increase of 90.68%. This surge was driven by the release of a CEO letter to shareholders, which outlined positive developments and strategic initiatives for the company.

NeueHealth, Inc. (NEUE) experienced a pre-market gain of 61.25%, with its stock reaching $6.95. The boost followed the announcement of a definitive merger agreement, under which the company will be acquired by an affiliate of New Enterprise Associates at an enterprise value of approximately $1.3 billion.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Despegar.com, Corp. (DESP)

Analyst Firm: TD Cowen
Upgrade: Sell to Hold
Price Target: $19.50
Yesterday's Close: $19.46

TD Cowen raised its rating on Despegar.com (DESP) from Sell to Hold, setting a new price target of $19.50, up from the previous $14.

Despegar.com, an online travel company serving both leisure and corporate travelers in Latin America and the U.S., has a stock price target range with a high of $25.00, a median of $20.75, and a low of $15.00. The average stock price target stands at $20.38.

2. Aclaris Therapeutics, Inc. (ACRS)

Analyst Firm: H.C. Wainwright
Upgrade: Neutral to Buy
Price Target: $20
Yesterday's Close: $2.89

H.C. Wainwright upgraded Aclaris Therapeutics, Inc. (ACRS) from Neutral to Buy, with a price target of $20.

Aclaris Therapeutics, a clinical-stage biopharmaceutical company focused on developing drug candidates for immune-inflammatory diseases in the U.S., has stock price targets ranging from a high of $20.00 to a low of $5.00. The median target is $7.50, with an average target of $10.00.

3. CAE Inc. (CAE)

Analyst Firm: Desjardins
Upgrade: Hold to Buy
Yesterday's Close: $24.55

Desjardins upgraded CAE Inc. (CAE) from Hold to Buy without any price target.

CAE Inc., which provides simulation training and operations support solutions across North America, Europe, Asia, Oceania, Africa, and the Americas, has stock price targets with a high of $27.84, a median of $23.97, and a low of $17.77. The average stock price target is $23.81.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.